Practical Issues of Preclinical Pharmacokinetic Investigations of New Drugs (Review)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Several issues with pharmacokinetic studies of new drugs, in particular, experiment planning, development of study protocols, dose selection, and administration routes, are reviewed. The number of used animals is justified statistically with respect to bioethics. The pharmacokinetic study protocol is discussed in more detail according to domestic regulatory requirements. Modern approaches to combining bioanalytical methods with pharmacokinetic studies are described.

About the authors

V. V. Chistyakov

People’s Friendship University of Russia, Common Use Center

Email: stepanova_25@inbox.ru
Russian Federation, Moscow, 117198

E. S. Stepanova

People’s Friendship University of Russia, Common Use Center

Author for correspondence.
Email: stepanova_25@inbox.ru
Russian Federation, Moscow, 117198

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature